Cargando…
Phosphodiesterase 4 inhibitor apremilast improves insulin resistance in psoriasis patients
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304264/ https://www.ncbi.nlm.nih.gov/pubmed/34961971 http://dx.doi.org/10.1111/1346-8138.16286 |
_version_ | 1784752064239239168 |
---|---|
author | Ikumi, Kyoko Torii, Kan Sagawa, Yoko Kanayama, Yoshifumi Nakada, Aya Nishihara, Haruna Morita, Akimichi |
author_facet | Ikumi, Kyoko Torii, Kan Sagawa, Yoko Kanayama, Yoshifumi Nakada, Aya Nishihara, Haruna Morita, Akimichi |
author_sort | Ikumi, Kyoko |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9304264 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93042642022-07-28 Phosphodiesterase 4 inhibitor apremilast improves insulin resistance in psoriasis patients Ikumi, Kyoko Torii, Kan Sagawa, Yoko Kanayama, Yoshifumi Nakada, Aya Nishihara, Haruna Morita, Akimichi J Dermatol Letters to the Editor John Wiley and Sons Inc. 2021-12-27 2022-04 /pmc/articles/PMC9304264/ /pubmed/34961971 http://dx.doi.org/10.1111/1346-8138.16286 Text en © 2021 The Authors. The Journal of Dermatology published by John Wiley & Sons Australia, Ltd on behalf of Japanese Dermatological Association https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Letters to the Editor Ikumi, Kyoko Torii, Kan Sagawa, Yoko Kanayama, Yoshifumi Nakada, Aya Nishihara, Haruna Morita, Akimichi Phosphodiesterase 4 inhibitor apremilast improves insulin resistance in psoriasis patients |
title | Phosphodiesterase 4 inhibitor apremilast improves insulin resistance in psoriasis patients |
title_full | Phosphodiesterase 4 inhibitor apremilast improves insulin resistance in psoriasis patients |
title_fullStr | Phosphodiesterase 4 inhibitor apremilast improves insulin resistance in psoriasis patients |
title_full_unstemmed | Phosphodiesterase 4 inhibitor apremilast improves insulin resistance in psoriasis patients |
title_short | Phosphodiesterase 4 inhibitor apremilast improves insulin resistance in psoriasis patients |
title_sort | phosphodiesterase 4 inhibitor apremilast improves insulin resistance in psoriasis patients |
topic | Letters to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304264/ https://www.ncbi.nlm.nih.gov/pubmed/34961971 http://dx.doi.org/10.1111/1346-8138.16286 |
work_keys_str_mv | AT ikumikyoko phosphodiesterase4inhibitorapremilastimprovesinsulinresistanceinpsoriasispatients AT toriikan phosphodiesterase4inhibitorapremilastimprovesinsulinresistanceinpsoriasispatients AT sagawayoko phosphodiesterase4inhibitorapremilastimprovesinsulinresistanceinpsoriasispatients AT kanayamayoshifumi phosphodiesterase4inhibitorapremilastimprovesinsulinresistanceinpsoriasispatients AT nakadaaya phosphodiesterase4inhibitorapremilastimprovesinsulinresistanceinpsoriasispatients AT nishiharaharuna phosphodiesterase4inhibitorapremilastimprovesinsulinresistanceinpsoriasispatients AT moritaakimichi phosphodiesterase4inhibitorapremilastimprovesinsulinresistanceinpsoriasispatients |